{"product_id":"dyskinesia-research-and-treatment-psychopharmacology-series-2-3642701426","title":"Dyskinesia: Research and Treatment (Psychopharmacology Series, 2)","description":"\u003cp\u003e\u003cstrong\u003eISBN:\u003c\/strong\u003e 3642701426\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAuthor:\u003c\/strong\u003e Casey, D.E.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCondition:\u003c\/strong\u003e New\u003c\/p\u003e\u003cp\u003eMore than a quarter century has passed since the initial descriptions of tardive dyskinesia (Schonecker, 1957; Sigwald et aI., 1959). The earliest epidemiologic study of this disorder was carried out in Roskilde, Denmark, by Uhrbrand and Faurbye (1960); the term tardive dyskinesia was first used a few years later in a subsequent paper (Faurbye et aI., 1964). Despite 25 years of intensive investiga- tive scrutiny, the syndrome persists, and approaches to its prevention and treat- ment continue to have limited efficacy. It is thus fitting to evaluate what has already been learned and consider future directions for research. . Tardive dyskinesia is generally dermed as an involuntary movement disorder, mainly involving the mouth, which attends long-term neuroleptic exposure. Beyond these simple facts, however, there has been relatively little consensus about this disorder. A desire to address the controversies associated with tardive dyskinesia prompted the organization of an international symposium at Kolle- kolle, just outside Copenhagen. This publication comprises all 26 presentations.\u003c\/p\u003e","brand":"Mia Karts","offers":[{"title":"Default Title","offer_id":51931652718880,"sku":"NEW3642701426","price":129.48,"currency_code":"USD","in_stock":true}],"url":"https:\/\/miakarts.com\/products\/dyskinesia-research-and-treatment-psychopharmacology-series-2-3642701426","provider":"Miakarts Books","version":"1.0","type":"link"}